Trial Profile
Princess Margaret Cancer Centre 18F-DCFPyL PET Registry
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Sep 2022
Price :
$35
*
At a glance
- Drugs Piflufolastat F18 (Primary)
- Indications Carcinoma; Prostate cancer
- Focus Diagnostic use
- Acronyms PM-PPR
- 01 Sep 2022 Results assessing performance of 18F-DCFPyL PET/CT or PET/MRI with bone scan and CT with or without multiparametric MRI using data from two clinical studies: NCT03535831 and NCT03718260 published in the Radiology
- 19 Apr 2021 Status changed from recruiting to active, no longer recruiting.
- 25 Sep 2018 Status changed from not yet recruiting to recruiting.